Feature stories
2013
-
April-2013
Technology, economy and science transform the battle against malaria
The initial goal of the Novartis Malaria Initiative was to deliver two million antimalarial treatments within four years. It long ago surpassed that goal, and over 500 million treatments have been delivered since 2001, contributing to a significant reduction of the death toll from malaria.
Read the article -
April-2013
How a rising middle class is reshaping healthcare in AfricaThere is good reason for optimism. A viable middle class is growing in many African nations, and the African Development Bank (ADB) estimates that it now numbers between 300 million and 500 million people.
Read the article
2012
-
November-2012
SMS for Life case study wins 2012 SIM Paper AwardsDr. Donald Marchand, Professor of Strategy Execution and Information Management at IMD in Lausanne, Switzerland, and Jim Barrington, Program Director for SMS for Life at the Novartis Malaria Initiative, have won the 2012 Society for Information Management (SIM) Best Paper Awards Competition.
Read the article -
06-Sep-2012
Using everyday technology to save livesThree speakers joined a recent Novartis Malaria Initiative event to examine the journey Novartis undertook to apply simple technology to help alleviate stockouts of malaria medicines in public health facilities in Africa. SMS for Life does this by tracking drug supply through the use of mobile phones and electronic mapping technology.
Visit the event center -
May-2012
Shaping the future of healthcare in Africa through technologyNovartis Malaria Initiative recently participated in the World Economic Forum on Africa, held in Addis Ababa, Ethiopia.
Read the article -
25-Apr-2012
Novartis hits 500 million antimalarial delivery-markSince 2001, working with a range of health organizations, we have provided 500 million antimalarial treatments, without profit to malaria-endemic countries, impacting more than one million lives.
Watch the message from Joseph Jimenez, Novartis CEO -
04-Apr-2012
Delivery of child-friendly antimalarial hits the 100 million markChildren are the most vulnerable to malaria. Every 60 seconds, a child dies from malaria in Africa. Yet, until recently there was no child-friendly treatment for these vulnerable patients.
Read the article
2011
-
06-Dec-2011
An unprecedented business model to fight malariaMalaria remains a complex and multi-faceted problem in sub-Saharan Africa. Three speakers joined a recent Novartis Malaria Initiative event to look more closely at the impact of malaria in Africa, and to examine the journey Novartis undertook to apply innovation and make global access possible for patients of all backgrounds, in all locations.
Read the article -
17-Nov-2011
The Novartis Malaria Initiative: lessons from a dramatic decadeIn 2001, Novartis AG and the World Health Organization (WHO) unveiled a unique 10-year alliance to provide a breakthrough medicine against malaria – without profit – for use by public health systems in developing countries.
Read the article
2010
-
23-Apr-2010
April 25 is World Malaria DayOn World Malaria Day, April 25, the international community highlights the campaign to provide effective control of this deadly disease.
Read the article
2009
-
24-Apr-2009
Novartis in the fight against malariaApril 25 is World Malaria Day, an opportunity to reflect on the progress made in finding sustainable solutions for malaria.
Read the article
